TY  - JOUR

T1  - Intensity of prior therapy influences minimal residual disease (MRD) detection and its clinical significance in childhood lymphoblastic leukaemia (ALL).

JO  - BLOOD

PY  - 1999/11/15

AU  - Frost L

AU  - Wilson G

AU  - Goodeve A

AU  - Peake I

AU  - Vora A

ED  - 

VL  - 94

IS  - 10

SP  - 203B

EP  - 203B

Y2  - 2025/04/28

ER  -